Prosthesis; Cardiac, Heart, Functional Disturbance as Result
3
0
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Sutureless
Research Leaders
6 sponsors active, led by Centre Cardiologique du Nord
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
Transcatheter Aortic Valve Implantation Versus Standard Surgical Aortic Valve Replacement
Aortic Valve Replacement Above the Aortic Annulus (SA-AVR) With the Carpentier-Edwards Magna-Ease Bioprosthesis
Rivaroxaban in Mechanical Valves: RMV Study
Research Network
Common Treatments
- Sutureless1
- Aortic Valve Replacement1
- Bioprothesis1
- Rivaroxaban1
- Transcatheter Aortic Valve Implantation1
Active Sponsors
- Centre Cardiologique du Nord1
- Henri Mondor University Hospital1
- Federal University of Bahia1
- Hospital Ana Nery1
- Universita degli Studi di Genova1
Top Investigators
Marie Lannelongue Hospital
Cardiac Surgery Centre Cardiologique du Nord de Saint-Denis, Paris, France
Related Conditions
- Prosthesis Survival1
- Aortic Valve Disease1